HUTCHMED (China) Limited (HCM)
LSE
Closed
Aug 24, 2026
Day's Range
178.0052 wk Range
150.48Overview - HCM - HUTCHMED (China) Limited
Key Statistics
Valuation
Enterprise Value
242.60M
P/E (Trailing)
‪184.00‬
P/E (Forward)
‪49.32‬
PEG Ratio
‪49.32‬
Price / Sales (TTM)
‪2.91‬
Price / Book
‪171.58‬
EV / EBITDA
‪-16.15‬
Profitability
Gross Margin
‪23.08%‬
Profit Margin
‪3.25%‬
Operating Margin
‪0.31%‬
Return on Assets
‪-1.23%‬
Return on Equity
‪1.46%‬
Ownership
Shares Outstanding
859.74M
Float
522.93M
Held by Insiders
‪38.79%‬
Held by Institutions
‪19.43%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪172.17‬
200-Day Avg
‪197.83‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Average price target
‪£ 325.47‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - HCM - HUTCHMED (China) Limited
Peers - HCM - HUTCHMED (China) Limited
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- HCMLSEHUTCHMED (China) Limited159.90BMarket Cap-23.64%52-week change184.00P/E (Trailing)‪3.25%‬Profit Margin
- HLNLSEHaleon plc3.19TMarket Cap+1.46%52-week change20.17P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change18.82P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc342.98BMarket Cap+2.31%52-week change—P/E (Trailing)‪-10.78%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB167.10BMarket Cap+37.04%52-week change47.34P/E (Trailing)‪15.54%‬Profit Margin
- 0O14LSEMerck KGaA63.83BMarket Cap+20.29%52-week change19.49P/E (Trailing)‪13.95%‬Profit Margin
- 0LERLSETeva Pharmaceutical Industries Ltd. ADR50.47BMarket Cap+49.95%52-week change29.67P/E (Trailing)‪51.78%‬Profit Margin
Profile Summary - HCM - HUTCHMED (China) Limited
About
HUTCHMED (China) Limited is an innovative, commercial-stage biopharmaceutical company headquartered in Hong Kong, focused on the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. Established over two decades ago as one of China's first…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
